Drugs modulating norepinephrine transmission by blocking the NET such as atomoxetine (Schwartz and Correll, 2014) or the alpha2-adrenergic agonists such as clonidine or guanfacine (Arnsten et al., 2007) are effective treatments for ADHD. The gene discussed is PSMA2; the disease is attention deficit-hyperactivity disorder.